Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAGE: GM-CSF Inhalation for Autoimmune Pulmonary Alveolar Proteinosis
jRCT1091220205Completed
- Sponsor
- Koh Nakata
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in autoimmune pulmonary alveolar proteinosis (aPAP) comparing GM-CSF inhalation with Placebo inhalation (2 arms). Started Jan 2015; status: completed.
02
Drugs
sargramostim
03
Conditions
autoimmune pulmonary alveolar proteinosis (aPAP)
Beyond the preview
Go deeper on jRCT1091220205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220205.